K. Hasumi et al., Isolation of SMTP-3, 4, 5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis, J ANTIBIOT, 51(12), 1998, pp. 1059-1068
Four novel triprenyl phenol metabolites, designated SMTP-3, -4, -5, and -6,
have been isolated from cultures of Stachybotrys microspora IFO 30018 by s
olvent extraction and successive chromatographic fractionation using silica
gel and silica ODS columns. A combination of spectroscopic analyses showed
that SMTP-3, -4, -5, and -6 are staplabin analogs, containing a serine, a
phenylalanine, a leucine or a tryptophan moiety in respective molecules in
place of the N-carboxybutyl portion of the staplabin molecule. SMTP-4, -5,
and -6 were active at 0.15 similar to 0.3 mM in enhancing urokinase-catalyz
ed plasminogen activation and plasminogen binding to fibrin, as well as pla
sminogen- and urokinase-mediated fibrinolysis. On the other hand, the conce
ntration of staplabin required to exert such effects was 0.4 similar to 0.6
mM, and SMTP-3 was inactive at concentrations up to 0.45 mM.